₹ 0.5 Cr
Volume transacted
1.8 K
stocks traded
Last Updated time: 05 Nov 13:54 PM
Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
YEARHIGH
₹ 3087.95
Last updated on: Nov 04, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
04 Nov 2024 | 2612.7 | 2729.7 | 2729.7 | 2602 |
01 Nov 2024 | 2729.7 | 2719.85 | 2746.15 | 2719.85 |
31 Oct 2024 | 2719.8 | 2701.3 | 2760 | 2678.05 |
30 Oct 2024 | 2677.25 | 2719.9 | 2739.8 | 2601 |
29 Oct 2024 | 2629.75 | 2648.95 | 2674.05 | 2620.9 |
28 Oct 2024 | 2642.35 | 2595.95 | 2668.7 | 2542.55 |
25 Oct 2024 | 2586.7 | 2668.25 | 2700 | 2505 |
24 Oct 2024 | 2618.5 | 2649.7 | 2684.5 | 2605 |
23 Oct 2024 | 2630.85 | 2629.95 | 2661.45 | 2567.75 |
22 Oct 2024 | 2581.9 | 2660 | 2674 | 2570.15 |
Date | Price |
---|---|
04 Nov 2024 | 2612.7 |
01 Nov 2024 | 2729.7 |
31 Oct 2024 | 2719.8 |
30 Oct 2024 | 2677.25 |
29 Oct 2024 | 2629.75 |
28 Oct 2024 | 2642.35 |
25 Oct 2024 | 2586.7 |
24 Oct 2024 | 2618.5 |
23 Oct 2024 | 2630.85 |
22 Oct 2024 | 2581.9 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr
Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...
30 Oct 202410:39
Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend
GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...
29 Oct 202416:10
GlaxoSmithKline Pharmaceuticals to declare Quarterly Result
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...
25 Oct 202410:38
GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore
Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...
03 Aug 202412:25
GlaxoSmithKline Pharmaceuticals to convene board meeting
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...
18 Jul 202410:38
Glaxosmithkline Pharmaceuticals announces change in senior management
Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...
05 Jul 202413:26
FAQs for 52 Week High of Glaxosmithkline Pharmaceuticals Ltd
What is the significance of Glaxosmithkline Pharmaceuticals Ltd reaching its 52-week high?
Why do investors monitor Glaxosmithkline Pharmaceuticals Ltd 52-week high?
Is Glaxosmithkline Pharmaceuticals Ltd a good buy when it hits its 52-week high?
What should I consider before investing in Glaxosmithkline Pharmaceuticals Ltd at its 52-week high?
Can Glaxosmithkline Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?
Unlimited trading at just
Rs. 199*